IDO1 INVOLVEMENT IN MEDULLOBLASTOMA: A POSSIBLE INTERACTION WITH mTOR

被引：0
|
作者：
Folgiero, Valentina [1 ]
del Bufalo, Francesca [1 ]
Carai, Andrea [1 ]
Cefalo, Maria Giuseppina [1 ]
Citti, Arianna [1 ]
Rutella, Sergio [1 ]
Locatelli, Franco [1 ]
Mastronuzzi, Angela [1 ]
机构：
[1] Bambino Gesu Pediat Hosp, Rome, Italy
来源：
NEURO-ONCOLOGY | 2014年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TB-023
引用
收藏
页码：141 / 141
页数：1
相关论文
共 50 条
  • [41] An adverse tumor-protective effect of IDO1 inhibition
    Kenski, Juliana C. N.
    Huang, Xinyao
    Vredevoogd, David W.
    de Bruijn, Beaunelle
    Traets, Joleen J. H.
    Ibanez-Molero, Sofia
    Schieven, Sebastiaan M.
    van Vliet, Alex
    Krijgsman, Oscar
    Kuilman, Thomas
    Pozniak, Joanna
    Loayza-Puch, Fabricio
    Terry, Alexandra M.
    Mueller, Judith
    Logtenberg, Meike E. W.
    de Bruijn, Marjolein
    Levy, Pierre
    Korner, Pierre-Rene
    Goding, Colin R.
    Schumacher, Ton N.
    Marine, Jean-Christophe
    Agami, Reuven
    Peeper, Daniel S.
    CELL REPORTS MEDICINE, 2023, 4 (02)
  • [42] Expression of IDO1 is regulated via Ras signaling pathways
    Lee, Eunji
    He, Felicia
    Choi, Byeong Hyeok
    Dai, Wei
    FASEB JOURNAL, 2022, 36
  • [43] Regulation of IDO1 expression and the kynurenine pathway in synovial fibroblasts
    Municho, Cristina
    Ergueta, Sandra
    Usategui, Alicia
    Del Rey, Manuel J.
    Pablos, Jose L.
    Criado, Gabriel
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [44] Targeting the IDO1 pathway in cancer: from bench to bedside
    Liu, Ming
    Wang, Xu
    Wang, Lei
    Ma, Xiaodong
    Gong, Zhaojian
    Zhang, Shanshan
    Li, Yong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [45] Synergistic Antitumor Efficacy of an Inhibitor of IDO1 and Cytotoxic Agents Which Induce IDO Activity
    Koblish, Holly K.
    Hansbury, Michael J.
    Bowman, Kevin J.
    Kelley, Jennifer A.
    Brown, Ryan
    Wayland, Brian
    Yue, Eddy W.
    Combs, Andrew P.
    Scherle, Peggy A.
    Fridman, Jordan S.
    JOURNAL OF IMMUNOTHERAPY, 2011, 34 (02) : 223 - 223
  • [46] Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors
    Platten, Michael
    Doeberitz, Nikolaus von Knebel
    Oezen, Iris
    Wick, Wolfgang
    Ochs, Katharina
    FRONTIERS IN IMMUNOLOGY, 2015, 5
  • [47] KRas plays a negative role in regulating IDO1 expression
    Peng, Xiandong
    Lee, Eunji
    Liang, Jialu
    Colon, Tania
    Tran, Franklin
    Choi, Byeong H.
    Dai, Wei
    TRANSLATIONAL ONCOLOGY, 2025, 51
  • [48] Discovery of IDO1 and DNA dual targeting antitumor agents
    Fang, Kun
    Wu, Shanchao
    Dong, Guoqiang
    Wu, Ying
    Chen, Shuqiang
    Liu, Jianhe
    Wang, Wei
    Sheng, Chunquan
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2017, 15 (47) : 9992 - 9995
  • [49] Quantification of IDO1 enzyme activity in normal and malignant tissues
    Zhai, Lijie
    Ladomersky, Erik
    Bell, April
    Dussold, Corey
    Cardoza, Krislyn
    Qian, Jun
    Lauing, Kristen L.
    Wainwright, Derek A.
    TUMOR IMMUNOLOGY AND IMMUNOTHERAPY - MOLECULAR METHODS, 2019, 629 : 235 - 256
  • [50] IDO1 and IDO2 gene expression analysis by quantitative polymerase chain reaction
    Maiwald, S.
    Wehner, R.
    Schmitz, M.
    Bornhaeuser, M.
    Loeb, S.
    Wassmuth, R.
    TISSUE ANTIGENS, 2011, 77 (02): : 136 - 142
12345